• Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 13 Jan 2025 03:31:15   America/Chicago


    Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Rhythm Pharmaceuticals, Inc.
    Read more...
Share on,